First Trust Advisors LP Enochian Biosciences Inc Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.93 - $8.73 $1,206 - $5,456	-625 Reduced 2.67%	22,776 $44,000
Q1 2022 May 13, 2022	SELL	$4.42 - $9.0 $5,149 - $10,485	-1,165 Reduced 4.74%	23,401 $193,000
Q4 2021 Feb 08, 2022	BUY	$6.71 - $12.55 $21,109 - $39,482	3,146 Added 14.69%	24,566 $179,000
Q3 2021 Nov 15, 2021	SELL	$4.56 - $7.88 $73,862 - $127,640	-16,198 Reduced 43.06%	21,420 $144,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $6.79 $3,871 - $8,942	-1,317 Reduced 3.38%	37,618 $187,000
Q1 2021 May 14, 2021	BUY	$3.02 - $4.51 $11,950 - $17,846	3,957 Added 11.31%	38,935 $138,000
Q4 2020 Feb 02, 2021	SELL	$2.82 - $3.55 $4,148 - $5,222	-1,471 Reduced 4.04%	34,978 $103,000
Q3 2020 Nov 05, 2020	BUY	$3.42 - $4.55 $124,655 - $165,842	36,449 New	36,449 $130,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.